Skip to main content
Article
Anti-CD45 Radioimmunotherapy Using the Alpha-Emitting Radionuclide 211 At Combined with Bone Marrow Transplantation Prolongs Survival in a Disseminated Murine Leukemia Model
Blood (2012)
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Aimee Kenoyer, Fred Hutchinson Cancer Research Center
  • Tom Bäck, University of Gothenburg
  • Ethan R. Balkin, University of Washington
  • Donald K. Hamlin, University of Washington
  • D Scott Wilbur, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, University of Washington
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, University of Washington
Publication Date
November 16, 2012
Citation Information
Johnnie J. Orozco, Aimee Kenoyer, Tom Bäck, Ethan R. Balkin, et al.. "Anti-CD45 Radioimmunotherapy Using the Alpha-Emitting Radionuclide 211 At Combined with Bone Marrow Transplantation Prolongs Survival in a Disseminated Murine Leukemia Model" Blood Vol. 120 Iss. 21 (2012) p. 4096 - 4096
Available at: http://works.bepress.com/john-pagel/152/